Processa Pharmaceuticals, Inc. Selling, General and Administrative Expense
Processa Pharmaceuticals, Inc. (PCSA) reported Selling, General and Administrative Expense of $397.77 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2019-05-14
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2019-03-31 was $397.77K, a 15.41% decline year-over-year.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2018-12-31 was $134.11K, a 65.05% decline year-over-year.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2018-09-30 was $451.36K, a 76.85% increase year-over-year.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2018-06-30 was $350.58K, a 193.45% increase year-over-year.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2018 was $1.44M, a 71.74% increase from fiscal 2017.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2017 was $838.27K, a 1098.07% increase from fiscal 2016.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2016 was $69.97K, a 92.60% decline from fiscal 2015.
- Processa Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2015 was $945.46K, a 53.19% decline from fiscal 2014.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed | Selling, General and Administrative Expense 27 month | Selling, General and Administrative Expense 30 month | Selling, General and Administrative Expense 33 month | Selling, General and Administrative Expense 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $397.77K 10-Q · filed 2019-05-14 | $531.88K derived: sum of 2 quarters · filed 2019-05-14 | $983.24K derived: sum of 3 quarters · filed 2019-05-14 | $1.33M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2018-12-31 | $134.11K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $585.47K derived: sum of 2 quarters · filed 2019-04-08 | $936.05K derived: sum of 3 quarters · filed 2019-04-08 | $1.44M 10-K/A · filed 2019-04-08 | ||||||||
| 2018-09-30 | $451.36K 10-Q · filed 2018-11-14 | $801.94K derived: sum of 2 quarters · filed 2018-11-14 | $1.31M 10-Q · filed 2018-11-14 | $1.66M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2018-06-30 | $350.58K 10-Q · filed 2018-08-14 | $853.92K 10-Q · filed 2018-08-14 | $1.20M derived: sum of 3 quarters · filed 2019-05-14 | $1.46M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2018-03-31 | $470.23K 10-Q · filed 2019-05-14 | $483.95K 10-Q · filed 2018-05-21 | $853.90K derived: sum of 2 quarters · filed 2019-05-14 | $1.11M derived: sum of 3 quarters · filed 2019-05-14 | $1.23M derived: sum of 4 quarters · filed 2019-05-14 | |||||||
| 2017-12-31 | $383.68K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $638.90K derived: sum of 2 quarters · filed 2019-04-08 | $758.36K derived: sum of 3 quarters · filed 2019-04-08 | $838.27K 10-K/A · filed 2019-04-08 | ||||||||
| 2017-09-30 | $255.22K 10-Q · filed 2018-11-14 | $163.77K 10-Q · filed 2017-11-20 | $374.69K derived: sum of 2 quarters · filed 2018-11-14 | $454.59K 10-Q · filed 2018-11-14 | $187.64K 10-Q · filed 2017-11-20 | $450.48K derived: sum of 4 quarters · filed 2018-11-14 | ||||||
| 2017-06-30 | $119.47K 10-Q · filed 2018-08-14 | $10.27K 10-Q · filed 2017-10-04 | $192.76K 10-Q · filed 2018-08-14 | $23.87K 10-Q · filed 2017-10-04 | $195.26K derived: sum of 3 quarters · filed 2018-08-14 | $199.65K derived: sum of 4 quarters · filed 2018-08-14 | ||||||
| 2017-03-31 | $94.02K 10-Q · filed 2018-05-21 | $13.60K 10-Q · filed 2017-10-04 | $75.79K derived: sum of 2 quarters · filed 2018-05-21 | $80.19K derived: sum of 3 quarters · filed 2018-05-21 | $83.47K derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | -$18.23K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$13.83K derived: sum of 2 quarters · filed 2017-11-20 | -$10.55K derived: sum of 3 quarters · filed 2017-11-20 | $69.97K 10-K · filed 2017-09-25 | ||||||||
| 2016-09-30 | $4.39K 10-Q · filed 2017-11-20 | $7.68K derived: sum of 2 quarters · filed 2017-11-20 | $88.19K 10-Q · filed 2017-11-20 | $128.02K derived: sum of 4 quarters · filed 2017-11-20 | ||||||||
| 2016-06-30 | $3.28K 10-Q · filed 2017-10-04 | $83.80K 10-Q · filed 2017-10-04 | $123.63K derived: sum of 3 quarters · filed 2017-10-04 | $207.78K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2016-03-31 | $80.52K 10-Q · filed 2017-10-04 | $120.34K derived: sum of 2 quarters · filed 2017-10-04 | $204.50K derived: sum of 3 quarters · filed 2017-10-04 | $566.53K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2015-12-31 | $39.83K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $123.98K derived: sum of 2 quarters · filed 2017-09-25 | $486.02K derived: sum of 3 quarters · filed 2017-09-25 | $945.46K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | $84.16K 10-Q · filed 2017-09-08 | $119.30K 10-Q · filed 2015-12-01 | $446.19K derived: sum of 2 quarters · filed 2017-09-08 | $905.63K 10-Q · filed 2017-09-08 | $1.19M 10-Q · filed 2015-12-01 | $730.63K derived: sum of 4 quarters · filed 2017-09-08 | ||||||
| 2015-06-30 | $362.03K 10-Q · filed 2017-08-30 | $467.04K 10-Q · filed 2015-08-19 | $821.47K 10-Q · filed 2017-08-30 | $1.07M 10-Q · filed 2015-08-19 | $646.47K derived: sum of 3 quarters · filed 2017-08-30 | $1.32M derived: sum of 4 quarters · filed 2017-08-30 | ||||||
| 2015-03-31 | $459.44K 10-Q · filed 2017-08-07 | $601.89K 10-Q · filed 2015-05-15 | $284.44K derived: sum of 2 quarters · filed 2017-08-07 | $961.84K derived: sum of 3 quarters · filed 2017-08-07 | $1.67M derived: sum of 4 quarters · filed 2017-08-07 | |||||||
| 2014-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $502.40K derived: sum of 2 quarters · filed 2017-06-19 | $1.21M derived: sum of 3 quarters · filed 2017-06-19 | $2.02M 10-K · filed 2017-06-19 | $2.84M 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | $677.40K 10-Q · filed 2015-12-01 | $1.39M derived: sum of 2 quarters · filed 2015-12-01 | $2.19M 10-Q · filed 2015-12-01 | $2.95M derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | $712.41K 10-Q · filed 2015-08-19 | $1.52M 10-Q · filed 2015-08-19 | $2.27M derived: sum of 3 quarters · filed 2015-08-19 | $2.93M derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | $805.00K 10-Q · filed 2015-05-15 | $1.56M derived: sum of 2 quarters · filed 2015-05-15 | $2.22M derived: sum of 3 quarters · filed 2015-05-15 | $2.89M derived: sum of 4 quarters · filed 2015-05-15 | $6.12M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $752.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $1.42M derived: sum of 2 quarters · filed 2015-04-14 | $2.08M derived: sum of 3 quarters · filed 2015-04-14 | $2.82M 10-K · filed 2015-04-14 | $5.31M 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $664.42K 10-Q · filed 2014-11-13 | $1.33M derived: sum of 2 quarters · filed 2014-11-13 | $2.07M 10-Q · filed 2014-11-13 | $2.74M derived: sum of 4 quarters · filed 2014-11-13 | $4.56M 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | $665.61K 10-Q · filed 2014-08-19 | $1.40M 10-Q · filed 2014-08-19 | $2.08M derived: sum of 3 quarters · filed 2014-08-19 | $2.60M derived: sum of 4 quarters · filed 2014-08-19 | $3.90M 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | $736.57K 10-Q · filed 2014-05-14 | $1.41M derived: sum of 2 quarters · filed 2014-05-14 | $1.93M derived: sum of 3 quarters · filed 2014-05-14 | $2.23M derived: sum of 4 quarters · filed 2014-05-14 | ||||||||
| 2012-12-31 | $674.09K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.19M derived: sum of 2 quarters · filed 2014-03-27 | $1.49M derived: sum of 3 quarters · filed 2014-03-27 | $1.88M 10-K · filed 2014-03-27 | ||||||||
| 2012-09-30 | $519.17K 10-Q · filed 2013-11-08 | $819.49K derived: sum of 2 quarters · filed 2013-11-08 | $1.21M 10-Q · filed 2013-11-08 | |||||||||
| 2012-06-30 | $300.32K 10-Q/A · filed 2013-09-06 | $690.38K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |